Roche, Merck, Novartis and others hike prices on 83 meds starting in July: analyst

It’s not uncommon for drugmakers to raise prices on big-selling meds to start each year and at each year's halfway point. So as the calendar turned to July, many companies marked the occasion with price increases in an indication that political pressure against pharma's price hikes may be waning.